Supplementary Table S1 from A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer

Abstract

Prior and concomitant therapies in patients from cohort A (HR+, HER2-) with intracranial clinical benefit.